The more we learn about the complexity of Alzheimer’s, the more we need to change the way we treat it

Researchers demonstrate that microRNA-132 can significantly affect different brain cells, with potential implications for Alzheimer’s disease.

Multiomic blood profiling measures health more accurately than BMI

Researchers have designed a “mini gene” therapy that could hold promise for treating Usher Syndrome Type 1F

Meet MAPSULES: metal iron-based nanocapsules that deliver targeted chemotherapy to solid tumors

PULSED – a self-sealing drug delivery depot – enables precise timing and tunable release of therapeutic doses

The case of Kathleen Folbigg shows how far the field has come, but there are still no medical interventions for sudden infant death syndrome.

An insight into the complexities of Alzheimer’s disease and the ongoing pursuit for breakthrough therapies

Could crystallization technology help bring new drugs to market?

Day One Bio commits to creating purposeful treatments for children with life-threatening diseases